← Leaderboards
Kevin P. Campbell
University Of Iowa
$16,898,890
Attributed
$18,167,040
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,118,415 · 17
By mechanism
U54$30,173,307 · 8
P50$13,500,566 · 6
RC2$2,536,301 · 1
R01$2,171,469 · 1
P30$736,772 · 1
Top collaborators
- Peter G Schultz2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Katherine Mathews$11,391,241
- Yvonne M Kobayashi$93,840
- Steven A Moore$8,462,275
Others in their field
Top investigators on “Muscular Dystrophies”
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$53,688,339
- Stephen J. Tapscott · Fred Hutchinson Cancer Center$24,320,230
- Elizabeth M McNally · University Of Chicago$24,290,327
- Eric P Hoffman · Reveragen Biopharma, Inc.$24,157,975
- Charles A Thornton · Virginia Commonwealth University$22,039,420
- Krista H Vandenborne · University Of Pennsylvania$21,082,899
Research focus
Muscular DystrophiesMuscleLaboratoriesCellsProteinsDystroglycanopathyUniversitiesEnvironmentDiagnosticMolecularResearch PersonnelCollaborationsFutureResourcesDiagnosisBiopsyGenesClinical TrialsTranslational ResearchMedical StudentsLamininAlpha DystroglycanTissuesEvaluation
Grant awards (80)
Muscular Dystrophy Specialized Research Center$1,508,350
P50 · FY2025 · NS · contact PI
Muscular Dystrophy Specialized Research Center$301,670
P50 · FY2025 · NS · contact PI
Muscular Dystrophy Specialized Research Center$301,670
P50 · FY2025 · NS · contact PI
Muscular Dystrophy Specialized Research Center$1,400,846
P50 · FY2024 · NS · contact PI
Muscular Dystrophy Specialized Research Center: Project 1$485,373
P50 · FY2024 · NS · contact PI
Core A: Administrative Core$171,037
P50 · FY2024 · NS · contact PI
Muscular Dystrophy Specialized Research Center$1,466,500
P50 · FY2023 · NS · contact PI
Muscular Dystrophy Specialized Research Center: Project 1$472,802
P50 · FY2023 · NS · contact PI
Core A: Administrative Core$146,319
P50 · FY2023 · NS · contact PI
Muscular Dystrophy Specialized Research Center$1,487,640
P50 · FY2022 · NS · contact PI
Muscular Dystrophy Specialized Research Center: Project 1$380,297
P50 · FY2022 · NS · contact PI
Core A: Administrative Core$150,994
P50 · FY2022 · NS · contact PI
Muscular Dystrophy Specialized Research Center$1,508,480
P50 · FY2021 · NS · contact PI
Muscular Dystrophy Specialized Research Center: Project 1$301,697
P50 · FY2021 · NS · contact PI
Muscular Dystrophy Specialized Research Center: Core A$301,694
P50 · FY2021 · NS · contact PI
Muscular Dystrophy Specialized Research Center$1,534,100
P50 · FY2020 · NS · contact PI
Muscular Dystrophy Specialized Research Center$400,507
P50 · FY2020 · NS · contact PI
Muscular Dystrophy Specialized Research Center$162,039
P50 · FY2020 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,488,336
U54 · FY2019 · NS · contact PI
Project I:Muscular Dystrophy Cooperative Research Center$379,412
U54 · FY2019 · NS · contact PI
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center$148,465
U54 · FY2019 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,487,365
U54 · FY2018 · NS · contact PI
Project I:Muscular Dystrophy Cooperative Research Center$378,442
U54 · FY2018 · NS · contact PI
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center$148,465
U54 · FY2018 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,486,422
U54 · FY2017 · NS · contact PI
Project I:Muscular Dystrophy Cooperative Research Center$377,499
U54 · FY2017 · NS · contact PI
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center$148,465
U54 · FY2017 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,485,506
U54 · FY2016 · NS · contact PI
Project I:Muscular Dystrophy Cooperative Research Center$376,583
U54 · FY2016 · NS · contact PI
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center$148,465
U54 · FY2016 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,496,660
U54 · FY2015 · NS · contact PI
Project I:Muscular Dystrophy Cooperative Research Center$385,363
U54 · FY2015 · NS · contact PI
CAMPBELL Administrative Core: Muscular Dystrophy Cooperative Research Center$147,005
U54 · FY2015 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,440,336
U54 · FY2014 · NS · contact PI
Mechanistic Causes and Therapeutic Strategies for Dystroglycan-related Muscular$455,386
U54 · FY2014 · NS · contact PI
Research Training and Education$126,024
U54 · FY2014 · NS · contact PI
Administrative$72,663
U54 · FY2014 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,438,714
U54 · FY2013 · NS · contact PI
Mechanistic Causes and Therapeutic Strategies for Dystroglycan-related Muscular$572,543
U54 · FY2013 · NS · contact PI
Research Training and Education$143,025
U54 · FY2013 · NS · contact PI
Administrative$115,914
U54 · FY2013 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,474,037
U54 · FY2012 · NS · contact PI
Mechanistic Causes and Therapeutic Strategies for Dystroglycan-related Muscular$532,061
U54 · FY2012 · NS · contact PI
Research Training and Education$141,819
U54 · FY2012 · NS · contact PI
Administrative$112,371
U54 · FY2012 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,456,645
U54 · FY2011 · NS · contact PI
Mechanistic Causes and Therapeutic Strategies for Dystroglycan-related Muscular$505,104
U54 · FY2011 · NS · contact PI
Research Training and Education$145,850
U54 · FY2011 · NS · contact PI
Administrative$112,569
U54 · FY2011 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,498,136
U54 · FY2010 · NS · contact PI
High-throughput genetic & small-molecule screening for therapeutic modifiers$910,336
RC2 · FY2010 · NS · contact PI
Mechanistic Causes and Therapeutic Strategies for Dystroglycan-related Muscular$485,741
U54 · FY2010 · NS · contact PI
Research Training and Education$149,091
U54 · FY2010 · NS · contact PI
Administrative$112,635
U54 · FY2010 · NS · contact PI
High-throughput genetic & small-molecule screening for therapeutic modifiers$1,625,965
RC2 · FY2009 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,343,787
U54 · FY2009 · NS · contact PI
Epsilon-sarcoglycan in LGMD Type 2D$488,985
R01 · FY2009 · AR · contact PI
Novel therapeutics strategies for Duchenne Muscular Dystrophy$317,272
U54 · FY2009 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$58,000
U54 · FY2009 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,348,902
U54 · FY2008 · NS · contact PI
Therapeutic Potentential of Epsilon-Sarcoglycan in LGMD Type 2D$322,090
R01 · FY2008 · AR · contact PI
Novel therapeutics strategies for Duchenne Muscular Dystrophy$306,092
U54 · FY2008 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,538,082
U54 · FY2007 · NS · contact PI
Novel therapeutics strategies for Duchenne Muscular Dystrophy$349,558
U54 · FY2007 · NS · contact PI
Therapeutic Potentential of Epsilon-Sarcoglycan in LGMD Type 2D$328,664
R01 · FY2007 · AR · contact PI
Muscular Dystrophy Cooperative Research Center$147,500
U54 · FY2007 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,430,434
U54 · FY2006 · NS · contact PI
Therapeutic Potent. of e-sarcoglycan in LGMD Type 2D$338,480
R01 · FY2006 · AR · contact PI
Novel therapeutics strategies for Duchenne MD$278,535
U54 · FY2006 · NS · contact PI
Muscular Dystrophy Cooperative Research Center$1,426,597
U54 · FY2005 · NS
Therapeutic Potent. of e-sarcoglycan in LGMD Type 2D$346,625
R01 · FY2005 · AR
Novel therapeutics strategies for Duchenne MD$272,034
U54 · FY2005 · NS
Administrative$183,397
U54 · FY2005 · NS
Epsilon-sarcoglycan in LGMD Type 2D$346,625
R01 · FY2004 · AR
ROLE OF DYSTROGLYCAN IN HEART DEVELOPMENT$443,122
P50 · FY2002 · HL
LIMB GIRDLE MUSCULAR DYSTROPHY GENE THERAPY$296,752
P30 · FY2002 · DK
ROLE OF DYSTROGLYCAN IN HEART DEVELOPMENT$443,122
P50 · FY2001 · HL
LIMB GIRDLE MUSCULAR DYSTROPHY GENE THERAPY$296,752
P30 · FY2001 · DK
LIMB GIRDLE MUSCULAR DYSTROPHY GENE THERAPY$143,268
P30 · FY2000 · DK
ROLE OF DYSTROGLYCAN IN HEART DEVELOPMENT$132,307
P50 · FY2000 · HL